Pathstone Family Office’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$204K Buy
6,438
+1,086
+20% +$34.3K ﹤0.01% 1508
2023
Q2
$220K Sell
5,352
-181
-3% -$7.45K ﹤0.01% 1100
2023
Q1
$206K Sell
5,533
-6,095
-52% -$227K ﹤0.01% 1078
2022
Q4
$3.52M Sell
11,628
-84
-0.7% -$25.4K 0.03% 350
2022
Q3
$654K Buy
11,712
+5,752
+97% +$321K 0.01% 947
2022
Q2
$308K Buy
5,960
+2,209
+59% +$114K 0.01% 781
2022
Q1
$273K Sell
3,751
-18
-0.5% -$1.31K 0.01% 784
2021
Q4
$445K Sell
3,769
-31
-0.8% -$3.66K 0.01% 597
2021
Q3
$509K Buy
3,800
+17
+0.4% +$2.28K 0.01% 505
2021
Q2
$613K Sell
3,783
-1,322
-26% -$214K 0.02% 403
2021
Q1
$410K Buy
5,105
+3,291
+181% +$264K 0.01% 390
2020
Q4
$99K Hold
1,814
﹤0.01% 388
2020
Q3
$36K Hold
1,814
﹤0.01% 400
2020
Q2
$38K Hold
1,814
﹤0.01% 348
2020
Q1
$22K Hold
1,814
﹤0.01% 409
2019
Q4
$266K Hold
1,814
﹤0.01% 377
2019
Q3
$24K Hold
1,814
﹤0.01% 370
2019
Q2
$30K Hold
1,814
﹤0.01% 395
2019
Q1
$31K Hold
1,814
﹤0.01% 370
2018
Q4
$25K Hold
1,814
0.01% 245
2018
Q3
$52K Buy
+1,814
New +$52K 0.02% 100
2018
Q2
Sell
-1,814
Closed -$38K 270
2018
Q1
$38K Hold
1,814
0.02% 119
2017
Q4
$35K Buy
+1,814
New +$35K 0.02% 72
2017
Q3
Sell
-1,814
Closed -$29K 288
2017
Q2
$29K Hold
1,814
0.01% 251
2017
Q1
$26K Buy
+1,814
New +$26K 0.01% 220
2016
Q4
Sell
-1,814
Closed -$31K 170
2016
Q3
$31K Hold
1,814
0.03% 77
2016
Q2
$39K Buy
+1,814
New +$39K 0.04% 62